Ultragenyx Pharmaceutical Inc.

By person

24 insiders · 254 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

KAKKIS EMIL D

President & CEO

$612.07K (3)

$36.98M (26)

−$36.37M

7,444,206

$101.02M

+1.5%

Sharp Shalini

EVP, Finance

—

$11.97M (25) scheduled

−$11.97M

97,812

$1.33M

+106.5%

Parschauer Karah Herdman

EVP and Chief Legal Officer

—

$10.02M (35) scheduled

−$10.02M

92,562

$1.26M

+498.4%

Bedrosian Camille L

EVP and Chief Medical Officer

—

$6.04M (12) scheduled

−$6.04M

46,720

$633.99K

—

Aliski William

Director

—

$5.45M (11)

−$5.45M

185,655

$2.52M

−9.4%

Kassberg Thomas Richard

CBO & EVP

—

$3.85M (11)

−$3.85M

264,730

$3.59M

+209.2%

SIEGALL CLAY B

Director

—

$2.97M (3) scheduled

−$2.97M

2,550

$34.60K

+36.0%

Pinion John Richard

See Remarks

—

$2.84M (11)

−$2.84M

133,142

$1.81M

+1,643%

Huizenga Theodore Alan

SVP, Chief Accounting Officer

—

$2.80M (37) scheduled

−$2.80M

67,863

$920.90K

+288.1%

Harris Erik

EVP & Chief Commercial Officer

—

$2.66M (19)

−$2.66M

118,410

$1.61M

+902.3%

Fust Matthew K

Director

—

$2.32M (8) scheduled

−$2.32M

33,696

$457.25K

+155.4%

Horn Howard

Chief Financial Officer

—

$1.80M (14) scheduled

−$1.80M

96,295

$1.31M

—

Huang Dennis Karl

See Remarks

—

$914.53K (6)

−$914.53K

147,845

$2.01M

+1,181%

Dier Mardi

CFO & Executive Vice President

—

$813.79K (6)

−$813.79K

66,695

$905.05K

—

Crombez Eric

EVP and Chief Medical Officer

—

$662.61K (8)

−$662.61K

111,189

$1.51M

+299.3%

Sanders Corazon (Corsee) D.

Director

—

$339.40K (6) scheduled

−$339.40K

21,095

$286.26K

—

SULIMAN SHEHNAAZ

Director

—

$144.19K (1) scheduled

−$144.19K

27,951

$379.30K

—

WELCH DANIEL G

Director

—

40,441

$548.78K

+2,057%

NARACHI MICHAEL

Director

—

40,441

$548.78K

+2,057%

Dunsire Deborah

Director

—

38,566

$523.34K

—

Ray Amrit

Director

—

31,116

$422.24K

—

Dallas Jayson Donald Alexander

EVP & Chief Commercial Officer

—

23,830

$323.37K

+77.9%

Hogenhuis Wladimir

Chief Operating Officer

—

18,703

$253.80K

—

Ekman Lars

Director

—

17,745

$240.80K

+846.4%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Ultragenyx Pharmaceutical Inc.

By person

Individual transactions

What was left out